Advancing Immune Insights: The Revolutionary Olink Target 48 Panel
Immune Biomarker Profiling: A New Frontier in Clinical Research UPPSALA, Sweden Olink Holding AB (Nasdaq: OLK) has announced the launch of its latest innovation, the Olink Target 48 Immune Surveillance panel. This state...
Jun 6, 2024
• Laboratory Analytical Instruments Industry
Announcement